United Kingdom· GB-APID-4658111000001105
Aldurazyme 500units/5ml concentrate for solution for infusion vials
A laronidase product containing laronidase, registered in United Kingdom by Sanofi. The same ATC class is registered in 12 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Laronidase is registered in 12 of 19 countries.
Countries holding a registration under ATC A16AB05 (laronidase), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Laronidase · ATC A16AB05
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Laronidase
- Manufacturer
- Sanofi
- Country
- United Kingdom (GB)
- ATC code
- A16AB05
- ATC class
- Laronidase
- Defined daily dose
- 1 TSD, E
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- October 2, 2026
Packs & prices · 3
- gtin5030045000203
- gtin5000283662150
- gtin5000283660668
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for laronidase.
Graded by severity as the source publishes them — 2 minor. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Laronidase · interactions on record
2 records
Same medicine, other countries
Laronidase in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaALDURAZYMESanofi B.V., Amsterdam
- United StatesALDURAZYMEGenzyme Corporation
- FinlandAldurazymeOrifarm Oy
- FranceALDURAZYME 100 U/ml, solution à diluer pour perfusionSANOFI (PAYS-BAS)
- IrelandAldurazyme 100 U/ml concentrate for solution for infusionSanofi B.V.
- BelgiumAldurazyme 100 U/mlSanofi
- Japanラロニダーゼ（遺伝子組換え）サノフィ
- NetherlandsAldurazyme, concentraat voor oplossing voor i.v. infusie, 100U/ml, 5 mlGenzyme Europe BV
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Aldurazyme
- Liechtenstein · Aldurazyme
- Norway · Aldurazyme
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/135a24c3-0779-414e-b0fd-f4ef22a00c44 GET /v1/drugs/135a24c3-0779-414e-b0fd-f4ef22a00c44?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "4658111000001105",
"desc": "Aldurazyme 500units/5ml concentrate for solution for infusion vials (Sanofi)",
"form": "Solution for infusion",
"vpid": "4672211000001103",
"source": "dmd",
"vtm_id": "776479001",
"strength": "100 unit",
"substance": "Laronidase",
"ingredient": "Laronidase",
"supplier_code": "9190711000001101"
}See everything about laronidase.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.